Citius Pharmaceuticals, Inc. | License Agreements | Business Contracts

Amended and Restated License, Development and Commercialization Agreement, dated as of February 26, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (Filed With SEC on December 15, 2021)

Amendment to Amended and Restated License, Development and Commercialization Agreement, dated as of August 9, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (Filed With SEC on December 15, 2021)

Amendment No. 2 to Amended and Restated License, Development and Commercialization Agreement, dated as of August 31, 2021, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (Filed With SEC on December 15, 2021)

License Agreement, dated October 6, 2020, between NoveCite, Inc. and Novellus Therapeutics, Limited (Filed With SEC on December 16, 2020)

Patent and Technology License Agreement, dated January 2, 2019, between the Board of Regents of the University of Texas System on behalf of the University of Texas M. D. Anderson... (Filed With SEC on February 14, 2019)

First Amendment, dated October 15, 2015, to Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron... (Filed With SEC on February 14, 2019)

Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc (Filed With SEC on February 14, 2019)

Citius Pharmaceuticals, Inc. (43) | License Agreements (7)